Corcept Therapeutics (FRA:HTD) Institutional Ownership : 43.87% (As of May. 23, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Corcept Therapeutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Corcept Therapeutics's institutional ownership is 43.87%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Corcept Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Corcept Therapeutics's Float Percentage Of Total Shares Outstanding is 71.04%.

Corcept Therapeutics Institutional Ownership Historical Data

The historical data trend for Corcept Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Institutional Ownership Chart

Corcept Therapeutics Historical Data

The historical data trend for Corcept Therapeutics can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	47.60	47.48	44.94	42.72	43.03	43.91	45.96	46.16	44.37	43.87

Corcept Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Corcept Therapeutics (FRA:HTD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corcept Therapeutics Inc (FRA:HTD) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

CORT:USA

Address

149 Commonwealth Drive, Menlo Park, CA, USA, 94025

Website

https://www.corcept.com

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.